Gilbert Cisneros
Gilbert Cisneros (D-CA) bought $15K-$50K of $JNJ (Johnson & Johnson Common Stock (JNJ) [ST]) on May 30, 2025, part of 47 transactions in this filing (25 buys, 22 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 45
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Suspicious Timing Detected
5 flagsGilbert Cisneros bought $15,001 - $50,000 in $JNJ on 2025-05-30, 6 days before the 'Treat and Reduce Obesity Act of 2025' (S1973) was introduced, which aims to expand Medicare coverage for obesity treatments.
Gilbert Cisneros bought $1,001 - $15,000 in $NOC on 2025-05-30, 6 days before the 'Secure Space Act of 2025' (S1962) was introduced, which aims to restrict foreign competition in the U.S. satellite and telecommunications market.
Gilbert Cisneros bought $1,001 - $15,000 in $PFE on 2025-05-30, 6 days before the 'Treat and Reduce Obesity Act of 2025' (S1973) was introduced, which aims to expand Medicare coverage for obesity treatments.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $JNJ | Johnson & Johnson Common Stock (JNJ) [ST] | $15K-$50K | $155.21 | — | — | May 30, 2025 |
| BUY | $ATRC | AtriCure, Inc. - Common Stock (ATRC) [ST] | $1K-$15K | $29.85 | $29.28 | -1.9% | May 6, 2025 |
| BUY | $BA | Boeing Company (BA) [ST] | $1K-$15K | $207.32 | — | — | May 30, 2025 |
| BUY | $DAY | Dayforce, Inc. Common Stock (DAY) [ST] | $1K-$15K | $59.26 | — | — | May 13, 2025 |
| BUY | $ENGQF | ENGIE SA ORD (ENGQF) [ST] | $1K-$15K | $20.92 | $32.93 | +57.4% | May 9, 2025 |
| BUY | $FWRG | First Watch Restaurant Group, Inc. - Common Stock (FWRG) [ST] | $1K-$15K | $17.05 | — | — | May 15, 2025 |
| BUY | $IR | Ingersoll Rand Inc. Common Stock (IR) [ST] | $1K-$15K | $84.50 | — | — | May 13, 2025 |
| BUY | $KMI | Kinder Morgan, Inc. Common Stock (KMI) [ST] | $1K-$15K | — | — | — | May 30, 2025 |
| BUY | $KKR | KKR & Co. Inc. Common Stock (KKR) [ST] | $1K-$15K | $116.21 | $101.83 | -12.4% | May 7, 2025 |
| BUY | $LHX | L3Harris Technologies, Inc. Common Stock (LHX) [ST] | $1K-$15K | $244.34 | — | — | May 30, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Treat and Reduce Obesity Act of 2025
The Treat and Reduce Obesity Act of 2025 would mandate Medicare Part D coverage of GLP-1 obesity drugs, unlocking a massive new payer market of ~27 million beneficiaries. $NVO and $LLY are the two direct beneficiaries. The bill is in early-stage committee referral with 22 bipartisan cosponsors; no companion bill has passed the House yet. Real market data shows $NVO gaining 15.56% over 30 days vs $LLY's +0.7%, suggesting the market may be overweighting Novo's near-term Medicare exposure given its larger U.S. obesity market share.
State-Based Universal Health Care Act of 2025
HR4406 is in very early legislative stages—referred to five committees with 34 cosponsors. No funding is authorized. The bill is not a near-term market factor for any healthcare company.
H.R. 1 — Budget Reconciliation Act (One Big Beautiful Bill)
H.R. 1 signed into law July 4, 2025, with agricultural and defense titles that structurally benefit ADM via stabilized commodity pricing and GD via authorized shipbuilding growth. However, 10 months post-enactment, market price action for both stocks (ADM +7.89% 7-day to $74.69; GD +9.59% 7-day to $343.24) is detached from this legislation, indicating other factors dominate.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.
Supporting Healthy Moms and Babies Act
The 'Supporting Healthy Moms and Babies Act' (HR3762) is an early-stage bill that would mandate comprehensive maternity/newborn care coverage without cost-sharing under ACA plans. With 28 cosponsors, a companion bill in the Senate, and referral to three committees, legislative progress is early but has nominal bipartisan support. Insurers UNH and CI face increased medical costs, while diagnostic labs LH and DGX benefit from higher utilization. No dollar amount is authorized or appropriated.
Medical Research for Our Troops Act
HR3906 (Medical Research for Our Troops Act) would restore $1.181B in military medical research funding, but the bill has been stalled in the House Appropriations Committee since June 2025 with zero legislative movement. Real market data shows healthcare stocks declining 3-8% over 30 days due to broader sector headwinds, not this bill. No actionable trade signal exists.
Secure Space Act of 2025
The Secure Space Act of 2025, reported favorably out of Senate Commerce on April 14, 2026, would bar the FCC from licensing foreign satellite operators deemed national security risks. This structurally reduces competitive pressure on domestic satcom providers $VSAT and $IRDM, expanding their addressable U.S. market. Despite recent 7-day declines, the legislative catalyst is a bullish counterweight at current levels.
Affordable Housing Equity Act of 2025
HR3964, the Affordable Housing Equity Act of 2025, is an early-stage bill that would increase the eligible basis for LIHTC projects serving extremely low-income households to 150%. It has been referred to the House Ways and Means Committee with only one cosponsor, indicating negligible near-term passage probability. No direct market impact is expected; the bill's effects on homebuilders and lenders are structural and contingent on future legislative progress.
RAMP Act
The RAMP Act (HR4056) is an early-stage bill that would restrict the Medicare Secondary Payer private right of action to group health plans only, granting legal relief to auto, liability, workers' compensation, and no-fault insurers. The bill is referenced to two committees and has only one cosponsor, indicating a long legislative path. For the named insurers—UnitedHealth, Cigna, Humana—the bill is largely neutral as they primarily operate group health plans, which retain existing litigation exposure.
Tackling Predatory Litigation Funding Act
HR3512, the Tackling Predatory Litigation Funding Act, proposes a 40.8% federal excise tax on litigation finance proceeds, directly targeting third-party funders. The bill is in early legislative stages, but the structural threat has already contributed to recent price declines in $BX, $KKR, and $APO. Investors should monitor committee markup for signs of momentum.
Other Filings by Gilbert Cisneros
Free — no credit card
Get the next Cisneros trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.